Patents by Inventor Xiaoya Ping

Xiaoya Ping has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibody for antagonizing and inhibiting binding of vascular endothelial growth factor to its receptor, and coding sequence
    Patent number: 9580498
    Abstract: A mouse monoclonal antibody for antagonizing and inhibiting binding of a vascular endothelial growth factor (VEGF) and its receptor (VEGF-R), and a heavy chain variable region and light chain variable region amino acid sequence thereof. Also disclosed are a humanized preparation process of the antibody and a heavy chain variable region and light chain variable region amino acid sequence of the humanized antibody. The humanized antibody or its derivative can act as an ingredient of a pharmaceutical composition or be prepared into a suitable pharmaceutical preparation, is administered alone or in combination with a chemotherapy drug or other treatment means, and is used in broad-spectrum treatment of various solid tumors such as colon cancer, breast cancer and rhabdomyosarcoma.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: February 28, 2017
    Assignee: SUZHOU STAINWEI BIOTECH INC.
    Inventors: Shiping Luo, Hongqun Hu, Zui Chen, Mingwen Cai, Yanan Sun, Haiyun Liu, Jianying Zhou, Xiaoqi Song, Xiaoya Ping, Siyu Chen, Donghong Shi, Yiqing Xu, Qunmin Zhou
  • MONOCLONAL ANTIBODY FOR ANTAGONIZING AND INHIBITING BINDING OF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR AND ITS RECEPTOR, AND CODING SEQUENCE AND USE THEREOF
    Publication number: 20160039921
    Abstract: A mouse monoclonal antibody for antagonizing and inhibiting binding of a vascular endothelial cell growth factor (VEGF) and its receptor (VEGF-R), and a heavy chain variable region and light chain variable region amino acid sequence thereof. Also disclosed are a humanized preparation process of the antibody and a heavy chain variable region and light chain variable region amino acid sequence of the humanized antibody. The humanized antibody or its derivative can act as an ingredient of a pharmaceutical composition or be prepared into a suitable pharmaceutical preparation, is administered alone or in combination with a chemotherapy drug or other treatment means, and is used in broad-spectrum treatment of various solid tumors such as colon cancer, breast cancer and rhabdomyosarcoma.
    Type: Application
    Filed: November 5, 2013
    Publication date: February 11, 2016
    Applicant: SUZHOU STAINWEI BIOTECH INC.
    Inventors: Shiping Luo, Hongqun Hu, Zui Chen, Mingwen Cai, Yanan Sun, Haiyun Liu, Jianying Zhou, Xiaoqi Song, Xiaoya Ping, Siyu Chen, Donghong Shi, Yiqing Xu, Qunmin Zhou